An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial PneumoniasWilliam D. Travis, Dominique Valeyre, Cory M. Hogaboam et al.|American Journal of Respiratory and Critical Care Medicine|2013Cited by 4.3k
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsPaul W. Noble, Roland M. du Bois, Carlo Albera et al.|The Lancet|2011Cited by 2.1k
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trialTalmadge E. King, Roland M. du Bois, Carlo Albera et al.|The Lancet|2009Cited by 530
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important DifferenceRoland M. du Bois, Athol U. Wells, Derek Weycker et al.|American Journal of Respiratory and Critical Care Medicine|2011Cited by 523
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.Marc A. Judson, The Wasog Sarcoidosis Organ Assessment Instrument Investigators, Ulrich Costabel et al.|PubMed|2014Cited by 504